CONICS

CONICS maps single-cell RNA sequencing (scRNA-seq) gene expression and quantifies copy-number alterations (CNAs) to assign expression profiles to tumor sub-clones and characterize clonal architecture and evolutionary dynamics.


Key Features:

  • Copy-Number Alteration Quantification: Quantifies copy-number alterations (CNAs) directly from scRNA-seq data to assess genomic instability within tumor cells.
  • Robust Separation of Cell Populations: Provides routines to separate neoplastic cells from tumor-infiltrating stromal cells for focused cancer cell analysis.
  • Inter-Clone Differential Expression Analysis: Compares gene expression between distinct tumor clones to identify clonal-specific expression patterns.
  • Intra-Clone Co-Expression Analysis: Analyzes gene co-expression within individual clones to explore functional networks and pathways active in sub-clones.

Scientific Applications:

  • Tumor Heterogeneity: Maps single-cell expression to tumor sub-clones to characterize intra-tumor heterogeneity at the transcriptional and genomic levels.
  • Tumor Phylogeny and Clonal Evolution: Integrates expression and genomic mutation data to relate gene expression patterns to tumor phylogenies and clonal evolution.
  • Progression, Metastasis, and Resistance Mechanisms: Identifies clonal-specific expression signatures relevant to tumor progression, metastasis, and therapeutic resistance.

Methodology:

Implemented in Python and R; performs noise reduction and normalization of scRNA-seq data; quantifies CNAs from scRNA-seq; integrates genomic mutation information to map expression to tumor sub-clones; includes routines for separating neoplastic from stromal cells and for inter-clone differential expression and intra-clone co-expression analyses.

Topics

Details

Tool Type:
command-line tool
Operating Systems:
Linux, Mac
Programming Languages:
R, Perl, Python
Added:
6/1/2018
Last Updated:
11/25/2024

Operations

Publications

Müller S, Cho A, Liu SJ, Lim DA, Diaz A. CONICS integrates scRNA-seq with DNA sequencing to map gene expression to tumor sub-clones. Bioinformatics. 2018;34(18):3217-3219. doi:10.1093/bioinformatics/bty316. PMID:29897414. PMCID:PMC7190654.

PMID: 29897414
PMCID: PMC7190654
Funding: - NCI Helen Diller Family Comprehensive Cancer Center: P30-CA82103-18 - UCSF Brain Tumor SPORE Career Development Award: P50-CA097257-13: 7017

Documentation